Summary It is known that angiogenesis plays an important role in the growth and metastasis of solid tumours. Several angiogenic factors have been identified and platelet-derived endothelial cell growth factor (PD-ECGF) is thought to be one such factor. Recently, it was reported that thymidine phosphorylase (dThdPase) is identical to PD-ECGF. Using immunohistochemical staining with an anti-dThdPase antibody, we investigated the correlation between dThdPase expression and the microvessel density in 120 gastric carcinomas. The microvessel density, determined by immunostaining for factor VIII-related antigen, was significantly higher in dThdPase-positive tumours than in dThdPase-negative tumours. There was a significant correlation between dThdPase expression and the increment of microvessel density. Moreover, regarding distant organ metastasis, the frequency of hepatic metastasis was significantly higher (P<0.01) in patients with dThdPase-positive tumours than in those with dThdPase-negative tumours. In summary, it was suggested that dThdPase expression is closely associated with the promotion of angiogenesis and hepatic metastasis in gastric carcinoma.
Solid tumours require neovascularisation for growth and metastasis (Folkman, 1990) . It is also thought that the degree of tumour angiogenesis is related to clinical outcome, suggesting that angiogenic properties are correlated with tumour aggressiveness (Bosari et al., 1992; Weidner et al., 1992; Gasparini et al., 1994) . In a previous study (Maeda et al., 1995) we also demonstrated that the microvessel count is an independent prognostic indicator in patients with gastric carcinoma.
Many investigators have demonstrated that tumour cell secretion and activation of various endothelial growth factors, termed angiogenic factors, play crucial roles in the formation of the neovasculature (Ishikawa et al., 1989; Zagzag et al., 1990; Toi et al., 1994) . However, there have been few studies on the correlation between the expression of angiogenic factors and progression of malignant tumours. Recently, it was reported that thymidine phosphorylase (dThdPase) is identical to platelet-derived endothelial cell growth factor (PD-ECGF), which is thought to be an angiogenic factor (Ishikawa et al., 1989; Furukawa et al., 1992; Haraguchi et al., 1994) .
In this study we investigated the correlation between dThdPase expression and gastric cancer progression by an immunohistochemical study using an anti-dThdPase monoclonal antibody.
Materials and methods

Clinical material
Resected specimens from 120 patients with gastric carcinoma who underwent gastrectomy at our institution were studied. The patients ranged in age from 40 to 81 years (average age 59.4 years); 87 were men and 33 were women (Table I) . No patient had received chemotherapy or radiation therapy before surgery. All patients were followed up at least 5 years after surgery. Throughout this report, the General Rules for Gastric Cancer were used for the pathological diagnosis and classification of variables (Japanese Research Society for Gastric Cancer, 1981 (sm) involvement) and stage I tumours, but not at a significant level. However, a significant difference was noted with respect to venous invasion by tumour. The dThdPasepositive rate was significantly higher (P<0.01) in patients with venous invasion than in those without such invasion. With regard to the correlation between distant organ metastasis and dThdPase expression, 15 patients had synchronous and six had metachronous hepatic metastases in patients with dThdPase-positive tumours (Table III) . However, neither synchronous nor metachronous hepatic metastases were observed in patients with dThdPase-negative tumours. The frequency of hepatic metastasis was significantly higher (P <0.05) in patients with dThdPase-positive tumours than in those with dThdPase-negative tumours, Figure 1 Immunohistochemical staining for dThdPase in cancer tissues of the stomach (original magnification x 200). There is a strong cytoplasmic staining of the tumour cells. (Table IV) . Table V shows the correlation between the microvessel count and dThdPase status. The mean microvessel count in dThdPase-positive tumours was 22.4 + 8.5 and was significantly higher than in dThdPase-negative tumours (P<0.01, Mann -Whitney U-test).
The prognosis of the 87 patients who underwent curative resection was studied. As shown in Figure 2 , we found the prognosis of the patients with dThdPase-positive tumours to be significantly (P<0.01, by log-rank test) worse than that of those with dThdPase-negative tumours. The 5 year survival rate in patients with dThdPase-positive tumours was 50.0% (24/48), which was significantly lower than the rate in those with dThdPase-negative tumours (84.6%, 33/39). However, multivariate analysis using the Cox's model showed that only 14.3+8.8a 12.5 (10.0-30.4) aMicrovessel count in patients with dThdPase-positive tumours was significantly higher than in those with dThdPase-negative tumours (P <0.01, Mann -Whitney U-test). s.d., standard deviation. (Table VI) .
Discussion
In this study, dThdPase expression was observed in 60.8% of gastric carcinoma and weak immunoreactivity was found in the endothelium, lymphocyte or macrophages invaded into tumour stroma. However, normal gastric mucosa was not immunoreactive with this antibody. Recently, Miwa et al. (1987) reported that the activity of dThdPase was markedly increased in tumour components as compared with normal tissues in a variety of tumours. Our results appear to be compatible with these data.
It is now well established that malignant tumours depend on neovascularisation for their growth and metastasis (Folkman, 1990) . Recently, several angiogenic factors have been identified and PD-ECGF is thought to be one such factor (Ishikawa et al., 1989; Furukawa et al., 1992; Toi et al., 1994 ). Ishikawa et al. (1989 and Usuki et al. (1992) reported that PD-ECGF stimulates the growth and chemotaxis of endothelial cells in vitro and possesses angiogenic activity in vivo. Moreover, Haraguchi et al. (1994) reported that dThdPase is identical to PD-ECGF and also has chemotactic and angiogenic activity. Toi et al. (1995) reported that dThdPase expression was significantly correlated with tumour microvessel density in breast cancer. In this study, we also demonstrated that dThdPase expression was associated with increment of microvessel density and microvessel count was significantly higher in dThdPasepositive tumours than in dThdPase-negative tumours. Therefore, dThdPase is considered to be an important regulator of tumour angiogenesis and is thought to induce a vascular stroma in gastric carcinoma.
Furthermore, the frequency of hepatic metastasis was significantly higher in patients with dThdPase-positive tumours than in those with dThdPase-negative tumours. The finding that neovascularisation is most prominent in dThdPase-positive tumours suggests that an enhanced vascular supply reflects an increased risk of metastasis. Tumour cells rarely shed into the circulation before the primary tumour is vascularised (Folkman, 1992) . It has been shown that greater numbers of tumour vessels increase the opportunity for tumour cells to enter the circulation (Liotta et al., 1976) . Moreover, newly formed capillaries have fragmented basement membranes and are leaky, making them more penetrable by tumour cells than mature vessels (Nagy et al., 1989) . Therefore, in the hypervascular tumours, the metastatic process may be enhanced by the 'leaky' nature of newly formed blood vessels facilitating vascular invasion.
With regard to prognosis, we observed a shorter survival in patients with dThdPase-positive tumours than in those with dThdPase-negative tumours, but multivariate analysis indicated that dThdPase expression is not an independent prognostic factor. However, when we examined the recurrence mode, metachronous hepatic metastases were significantly more frequent in patients with dThdPase-positive tumours. Hepatic metastasis is one of the most important causes of death in patients with gastric carcinoma. To improve survival in patients with gastric carcinoma, the prediction of metachronous hepatic metastasis is therefore important. Our results suggest that the presence of dThdPase expression was not strongly associated with clinical outcome, but was useful in predicting metachronous hepatic metastases in patients with gastric carcinoma.
5-Fluorouracil (5-FU) is an anti-cancer drug used to treat a variety of neoplastic diseases, particularly cancers of the digestive organs. 5'-Deoxy-5-fluorouridine (5'-DFUR) is a prodrug of 5-FU and is converted to 5-FU by dThdPase (Ishitsuka et al., 1980; Miwa et al., 1987) . Recently, Fujii et al. (1994) reported that 5'-DFUR is effective in primary tumour regression and liver metastasis prevention. Such agents may be effective anti-tumour chemotherapeutic agents with less toxicity in patients with dThdPase-positive tumours.
Abbreviations dThdPase, thymidine phosphorylase; PD-ECGF, platelet-derived endothelial cell growth factor; F-VIII RAg, factor VIII-related antigen; m, mucosal neoplastic involvement; sm, submucosal neoplastic involvement; pm, muscle layer neoplastic involvement; ss, subserosal neoplastic involvement; se, serosal neoplastic involvement; sei, serosal involvement with directly infiltrating other organs beyond serosa.
